News

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
Rising teen obesity prompts a surge in Novo Nordisk's Wegovy usage among adolescents, with prescriptions climbing 50% in 2024 ...
A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.
Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
Financial Stability: Eli Lilly's balance sheet is more robust, with debt making up only 4% of equity, considerably less than ...
William Tong has taken legal action against two online distributors, Triggered Brand and Made In China, for allegedly selling research-grade GLP-1 weight loss drugs directly to Connecticut consumers ...
The direct-to-consumer telehealth company said the workforce reduction is unrelated to its weight-loss drug sector.
Regeneron said on Monday its experimental drug helped patients preserve up to 51% of lean mass and lose more fat when used in ...
The overturning of the FDA’s lab-developed tests rule is just the tip of the iceberg. With the loss of Chevron deference, ...
Biocon is gearing up to become a dominant player in the diabetes and obesity drug market. This comes as the pharma world ...